| 1 | [SID26725298] | Active | Potency | 0.0022 | Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2572, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.0022 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2572 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 2 | [SID26725298] | Active | Potency | 0.0089 | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory] | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.0089 [uM] | | BioAssay | qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) | | AID | 2517 | | BioAssay type | confirmatory | | Target | Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812] | | PubMed | | | Data Table |  |
|
| 3 | [SID26725298] | Active | Potency | 0.0316 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation [AID504374, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.0316 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation | | AID | 504374 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 4 | [SID26725298] | Active | Potency | 0.0316 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation [AID504374, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.0316 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation | | AID | 504374 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 5 | [SID26725298] | Active | Potency | 0.0891 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay [AID504375, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.0891 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay | | AID | 504375 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 6 | [SID26725298] | Active | Potency | 0.0891 | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay [AID504375, Type: confirmatory] | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.0891 [uM] | | BioAssay | qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay | | AID | 504375 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873] | | PubMed | | | Data Table |  |
|
| 7 | [SID26725298] | Active | Potency | 0.1 | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.1 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 8 | [SID26725298] | Active | Potency | 0.1122 | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.1122 [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 9 | [SID26725298] | Active | Potency | 0.1778 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.1778 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 10 | [SID26725298] | Active | Potency | 0.1778 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.1778 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 11 | [SID26725298] | Active | Potency | 0.4467 | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2708, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.4467 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2708 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 12 | [SID26725298] | Active | EC50 | 0.6 | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao. [AID1871, Type: confirmatory] | RGS7 [Homo sapiens] [gi:1166512] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | EC50 | 0.6 [uM] | | BioAssay | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao. | | AID | 1871 | | BioAssay type | confirmatory | | Target | RGS7 [Homo sapiens] [gi:1166512] | | PubMed | | | Data Table |  |
|
| 13 | [SID26725298] | Active | Potency | 0.7079 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 14 | [SID26725298] | Active | Potency | 0.7079 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 15 | [SID26725298] | Active | Potency | 0.8913 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter [AID463254, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter | | AID | 463254 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 16 | [SID26725298] | Active | Potency | 0.8913 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter [AID463254, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter | | AID | 463254 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 17 | [SID26725298] | Active | IC50 | 0.95 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | 0.95 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 18 | [SID26725298] | Active | IC50 | 0.95 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | 0.95 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 19 | [SID26725298] | Active | IC50 | 0.95 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | 0.95 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 20 | [SID26725298] | Active | EC50 | 1.03 | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. [AID1872, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301151] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | EC50 | 1.03 [uM] | | BioAssay | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. | | AID | 1872 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301151] | | PubMed | | | Data Table |  |
|
| 21 | [SID26725298] | Active | EC50 | 1.03 | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. [AID1872, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301151] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | EC50 | 1.03 [uM] | | BioAssay | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. | | AID | 1872 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301151] | | PubMed | | | Data Table |  |
|
| 22 | [SID26725298] | Active | EC50 | 1.03 | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. [AID1872, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301151] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | EC50 | 1.03 [uM] | | BioAssay | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao. | | AID | 1872 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301151] | | PubMed | | | Data Table |  |
|
| 23 | [SID26725298] | Active | Potency | 1.5101 | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 1.5101 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 24 | [SID26725298] | Active | IC50 | 1.52267 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | 1.52267 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 25 | [SID26725298] | Active | IC50 | 1.52267 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | 1.52267 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 26 | [SID26725298] | Active | IC50 | 1.52267 | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors [AID1417, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | 1.52267 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors | | AID | 1417 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 27 | [SID26725298] | Active | Potency | 1.5728 | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 1.5728 [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 28 | [SID26725298] | Active | Potency | 1.5728 | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 1.5728 [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 29 | [SID26725298] | Active | Potency | 1.5728 | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 1.5728 [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 30 | [SID26725298] | Active | EC50 | 1.67 | Dose respone, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. [AID1888, Type: confirmatory] | regulator of G-protein signaling 16 [Homo sapiens] [gi:156416009] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | EC50 | 1.67 [uM] | | BioAssay | Dose respone, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao. | | AID | 1888 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 16 [Homo sapiens] [gi:156416009] | | PubMed | | | Data Table |  |
|
| 31 | [SID26725298] | Active | Potency | 2.9362 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 2.9362 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID26725298] | Active | Potency | 3.2944 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 3.2944 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID26725298] | Active | Potency | 3.9716 | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 3.9716 [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 34 | [SID26725298] | Active | EC50 | 5.73 | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao. [AID1884, Type: confirmatory] | regulator of G-protein signaling 19 [Homo sapiens] [gi:86990435] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | EC50 | 5.73 [uM] | | BioAssay | Dose response, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao. | | AID | 1884 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 19 [Homo sapiens] [gi:86990435] | | PubMed | | | Data Table |  |
|
| 35 | [SID26725298] | Active | IC50 | 11.2 | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. [AID1986, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | 11.2 [uM] | | BioAssay | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. | | AID | 1986 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 36 | [SID26725298] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Galactokinase (GALK) [AID1868, Type: confirmatory] | galactokinase [Homo sapiens] [gi:4503895] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Galactokinase (GALK) | | AID | 1868 | | BioAssay type | confirmatory | | Target | galactokinase [Homo sapiens] [gi:4503895] | | PubMed | | | Data Table |  |
|
| 37 | [SID26725298] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Galactokinase (GALK) [AID1868, Type: confirmatory] | galactokinase [Homo sapiens] [gi:4503895] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Galactokinase (GALK) | | AID | 1868 | | BioAssay type | confirmatory | | Target | galactokinase [Homo sapiens] [gi:4503895] | | PubMed | | | Data Table |  |
|
| 38 | [SID26725298] | Active | Potency | 15.8489 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 39 | [SID26725298] | Active | Potency | 28.1838 | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction [AID2662, Type: confirmatory] | MLL gene product [Homo sapiens] [gi:56550039] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction | | AID | 2662 | | BioAssay type | confirmatory | | Target | MLL gene product [Homo sapiens] [gi:56550039] | | PubMed | | | Data Table |  |
|
| 40 | [SID26725298] | Active | Potency | 31.6228 | Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay [AID2711, Type: confirmatory] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay | | AID | 2711 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID26725298] | Active | Potency | 31.6228 | Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay [AID2712, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay | | AID | 2712 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID26725298] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 43 | [SID26725298] | Active | IC50 | 9999 | Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU) [AID1376, Type: confirmatory] | UDP-N-acetylglucosamine pyrophosphorylase glmU [Mycobacterium tuberculosis H37Rv] [gi:15608158] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | 9999 [uM] | | BioAssay | Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU) | | AID | 1376 | | BioAssay type | confirmatory | | Target | UDP-N-acetylglucosamine pyrophosphorylase glmU [Mycobacterium tuberculosis H37Rv] [gi:15608158] | | PubMed | | | Data Table |  |
|
| 44 | [SID26725298] | Active | | | Dose respone, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao. [AID1869, Type: confirmatory] | RGS8 protein [Homo sapiens] [gi:74355113] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | BioAssay | Dose respone, multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao. | | AID | 1869 | | BioAssay type | confirmatory | | Target | RGS8 protein [Homo sapiens] [gi:74355113] | | PubMed | | | Data Table |  |
|
| 45 | [SID26725298] | Active | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 46 | [SID26725298] | Active | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 47 | [SID26725298] | Active | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|
| 48 | [SID26725298] | Active | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) [AID2014, Type: confirmatory] | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP) | | AID | 2014 | | BioAssay type | confirmatory | | Target | polyadenylate-binding protein 1 [Homo sapiens] [gi:46367787] | | PubMed | | | Data Table |  |
|
| 49 | [SID26725298] | Active | IC50 | | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) [AID2012, Type: confirmatory] | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H) | | AID | 2012 | | BioAssay type | confirmatory | | Target | Eukaryotic translation initiation factor 4H [Homo sapiens] [gi:45219878] | | PubMed | | | Data Table |  |
|
| 50 | [SID26725298] | Active | | | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation [AID782, Type: screening] | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26725298 | | CID | 16745534 | | Outcome | Active | | BioAssay | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation | | AID | 782 | | BioAssay type | screening | | Target | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] | | PubMed | | | Data Table |  |
|